MURFU — Conduit Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- $989.08m
- $989.55m
2021 December 31st | 2022 December 31st | |
---|---|---|
Period Length: | 12 M | 12 M |
Source: | 10-K | 10-K |
Standards: | USG | USG |
Status: | Final | Final |
Net Income/Starting Line | -0.004 | 0.399 |
Non-Cash Items | 0.004 | -1.98 |
Other Non-Cash Items | ||
Changes in Working Capital | -0.006 | 0.266 |
Change in Prepaid Expenses | ||
Change in Other Assets | ||
Change in Accrued Expenses | ||
Change in Taxes Payable | ||
Cash from Operating Activities | -0.006 | -1.31 |
Other Investing Cash Flow Items | — | -135 |
Purchase of Investments | ||
Cash from Investing Activities | — | -135 |
Financing Cash Flow Items | -0.045 | -3.11 |
Other Financing Cash Flow | ||
Net Issuance / Retirement of Stock | ||
Net Issuance / Retirement of Debt | ||
Cash from Financing Activities | 0.055 | 137 |
Beginning Cash Balance | ||
Ending Cash Balance | ||
Net Change in Cash | 0.049 | 0.297 |